• Info
  • Insider Ownership

Insider Trading & Ownership of Kevin Joseph Fitzgerald

Location
Cambridge, MA
Summary
The estimated net worth of Kevin Joseph Fitzgerald is at least $6,883,494 dollars as of 06 Mar 2026. Kevin Joseph Fitzgerald is the CSO & EVP, Head of Research of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $6.88M.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
All Insider Reports
All Insider Reports

Notify me when Kevin Joseph Fitzgerald files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kevin Joseph Fitzgerald

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. CSO & EVP, Head of Research $6,883,494 -$11,370,630 -62% 04 Mar 2026
OVID Ovid Therapeutics Inc. Director 26 Feb 2026

Insider Transactions Reported by Kevin Joseph Fitzgerald:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.